Can-Fite BioPharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CANF and other ETFs, options, and stocks.

About CANF

Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602.

CEO

Motti Farbstein

CEOMotti Farbstein

Employees

Employees5

Headquarters

Ramat Gan, HaMerkaz

HeadquartersRamat Gan, HaMerkaz

Founded

1994

Founded1994

Employees

Employees5

CANF Key Statistics

Market cap

7.56M

Market cap7.56M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

4.07M

Average volume4.07M

High today

$3.61

High today$3.61

Low today

$3.41

Low today$3.41

Open price

$3.45

Open price$3.45

Volume

20.52K

Volume20.52K

52 Week high

$46.60

52 Week high$46.60

52 Week low

$3.36

52 Week low$3.36

CANF News

TipRanks 1d

Can-Fite Secures Israeli Patent to Bolster Namodenoson Anti-Obesity Franchise

Can-Fite BioPharma ( (CANF) ) has provided an update. On March 17, 2026, Can-Fite BioPharma announced that the Israeli Patent Office allowed its patent applica...

TipRanks 1d

Can-Fite BioPharma announces Israeli patent allowance for namodenoson

Can-Fite BioPharma (CANF) announced that the Israeli Patent Office has allowed its patent application No. 284463, titled “An A3 Adenosine Receptor Ligand for Us...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.